Health Care • Biotechnology: Electromedical & Electrotherapeutic Apparatus
$126.59 ▲ +0.07
(+0.06%)
MKT CAP: $4.30B • VOL: 571.7K
52W L $64 52W H $127
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$106
MEDIAN
$142
MEAN
$144
HIGH
$172
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ITGR TAPE
ITGR // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $153.17 | $145.58 | 2025-02-14 | $115.20 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $159.50 | $149.38 | 2025-02-06 | $118.99 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $144.31 | $139.25 | 2025-01-29 | $121.53 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $129.12 | — | 2025-01-17 | $124.06 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $111.40 | $120.26 | 2025-01-09 | $112.67 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $150.64 | $131.65 | 2024-12-18 | $110.13 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $122.79 | $127.86 | 2024-12-04 | $117.73 | -4.3% | 48% | C |